We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Industry CEOs Pledge to Adopt Unified Stance on Fees
Generic Industry CEOs Pledge to Adopt Unified Stance on Fees
March 2, 2011
The chief executives of several of the world’s biggest generic-drug makers have pledged to bring a “holistic approach” into user-fee negotiations with the FDA.